Who
C. Randal Mills
President and CEO
Company insider
Files Form 4 as: President and CEO, Elutia; President & CEO, Osiris Therapeutics.
In numbers
- Trades disclosed
- 98
- Buys
- 3
- Sells
- 0
- Bought
- $15K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 20 Dec 2006
- Last trade
- 10 Sep 2026
- Last filed
- 14 Sep 2026
Companies traded
Activity over time
1 Nov 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Sep 2026filed 14 Sep 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code M | —27,083 | filing |
| 10 Sep 2026filed 14 Sep 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code F | $7,7749,718 at $0.80 | filing |
| 10 Sep 2026filed 14 Sep 2026 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code M | —27,083 at $0.00 | filing |
| 10 Sep 2026filed 14 Sep 2026 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code M | —27,083 at $0.00 | filing |
| 10 Sep 2026filed 14 Sep 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code M | —27,083 | filing |
| 10 Sep 2026filed 14 Sep 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code F | $7,7749,718 at $0.80 | filing |
| 21 Jun 2026filed 22 Jun 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code M | —22,473 | filing |
| 21 Jun 2026filed 22 Jun 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code F | $8,5488,064 at $1.06 | filing |
| 21 Jun 2026filed 22 Jun 2026 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code M | —22,473 at $0.00 | filing |
| 21 Jun 2026filed 22 Jun 2026 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code M | —22,473 at $0.00 | filing |
| 21 Jun 2026filed 22 Jun 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code M | —22,473 | filing |
| 21 Jun 2026filed 22 Jun 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code F | $8,5488,064 at $1.06 | filing |
| 10 Jun 2026filed 12 Jun 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code M | —27,083 | filing |
| 10 Jun 2026filed 12 Jun 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code F | $10K9,718 at $1.04 | filing |
| 10 Jun 2026filed 12 Jun 2026 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code M | —27,083 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code M | —27,083 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code M | —27,083 | filing |
| 10 Jun 2026filed 12 Jun 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code F | $10K9,718 at $1.04 | filing |
| 10 Mar 2026filed 12 Mar 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code M | —27,084 | filing |
| 10 Mar 2026filed 12 Mar 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code F | $12K11,100 at $1.09 | filing |
News
No headline names them, or the companies they trade most, lately.